CReM in the News

CReM Investigators Publish Differentiation of Stem Cells to Lung Progenitors

See the original publication in Cell Stem Cell: “Efficient Derivation of Purified Lung and Thyroid Progenitors from Embryonic Stem Cells.”

See the article in BU Today!

CReM Investigators Publish Research into Differentiation Capacity of iPSC

See the press release!

See the original publication in the Journal of Clinical Investigation: “Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes.”

CReM Directors Profiled in Bostonia
bostonia screenshot

CReM Investigators publish humanized version of the novel Stem Cell Reprogramming Vector “STEMCCA”

click here to link to the publication in Stem Cells

CReM Investigators derive the first iPS cells specific for lung disease, from individuals with Cystic Fibrosis or alpha-1 antitrypsin deficiency-related emphysema

Click here to link to the Stem Cells journal publication

MGH and CReM investigators engineer bioartificial rat lung

Bioartificial lung Investigators used a mild detergent to remove resident cells from a harvested rat lung, leaving a white scaffold that was reseeded with endothelial and epithelial cells.  This bioartificial lung was characterized in vitro and successfully transplanted into a rat.  Read press releases at Boston.com, Reuters, and PhysOrg.com.

CReM Investigators publish novel approach to gene therapy for pulmonary emphysema

Life-long gene expression in lung tissue achieved by in vivo lentiviral transduction of long-lived pulmonary alveolar macrophages.  Press releases can be found at U.S. News & World Report and Science Blog.
Click here to view the Journal of Clinical Investigation publication of the method.

ARRA stimulus grant from the NIH Awarded to CReM: RC2 ‘Grand Opportunities (GO)’ Grant to study iPS Cells

CReM researchers have been awarded an RC2 GO grant to derive differentiated endodermal and hematopoietic lineages from human iPS cells.
The multicenter study, lead by Boston University Principal Investigators, Drs. Darrell Kotton and Gustavo Mostoslavsky, applies reprogramming technology to derive human iPS cells and then characterize their differentiated progeny using bioinformatics approaches. Click here to read the NIH press release.

On-line summaries of the latest publications this year from CReM investigators:

coverfig

Cardoso Lab on journal cover

 

 

Mouse iPS Cell Colonies

Mouse iPS Cell Colonies

Contact|Directory|BUMC
April 6, 2012
Primary teaching affiliate
of BU School of Medicine